BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

563 related articles for article (PubMed ID: 32324495)

  • 1. BET Epigenetic Reader Proteins in Cardiovascular Transcriptional Programs.
    Borck PC; Guo LW; Plutzky J
    Circ Res; 2020 Apr; 126(9):1190-1208. PubMed ID: 32324495
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Apabetalone (RVX-208) reduces vascular inflammation in vitro and in CVD patients by a BET-dependent epigenetic mechanism.
    Tsujikawa LM; Fu L; Das S; Halliday C; Rakai BD; Stotz SC; Sarsons CD; Gilham D; Daze E; Wasiak S; Studer D; Rinker KD; Sweeney M; Johansson JO; Wong NCW; Kulikowski E
    Clin Epigenetics; 2019 Jul; 11(1):102. PubMed ID: 31300040
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epigenetic Readers of Lysine Acetylation Regulate Cocaine-Induced Plasticity.
    Sartor GC; Powell SK; Brothers SP; Wahlestedt C
    J Neurosci; 2015 Nov; 35(45):15062-72. PubMed ID: 26558777
    [TBL] [Abstract][Full Text] [Related]  

  • 4. FAM222A, Part of the BET-Regulated Basal Endothelial Transcriptome, Is a Novel Determinant of Endothelial Biology and Angiogenesis-Brief Report.
    Tzani A; Haemmig S; Cheng HS; Pérez-Cremades D; Heuschkel MA; Jamaiyar A; Singh SA; Aikawa M; Yu PB; Wang T; Sun Y; Feinberg MW; Plutzky J
    Arterioscler Thromb Vasc Biol; 2024 Jan; 44(1):143-155. PubMed ID: 37942611
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bromodomain and extraterminal domain-containing protein inhibition attenuates acute inflammation after spinal cord injury.
    Rudman MD; Choi JS; Lee HE; Tan SK; Ayad NG; Lee JK
    Exp Neurol; 2018 Nov; 309():181-192. PubMed ID: 30134146
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bromodomains: Structure, function and pharmacology of inhibition.
    Ferri E; Petosa C; McKenna CE
    Biochem Pharmacol; 2016 Apr; 106():1-18. PubMed ID: 26707800
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epigenetic blockade of neoplastic transformation by bromodomain and extra-terminal (BET) domain protein inhibitor JQ-1.
    Zhang C; Su ZY; Wang L; Shu L; Yang Y; Guo Y; Pung D; Bountra C; Kong AN
    Biochem Pharmacol; 2016 Oct; 117():35-45. PubMed ID: 27520485
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epigenetic Modulation by Apabetalone Counters Cytokine-Driven Acute Phase Response
    Wasiak S; Gilham D; Daze E; Tsujikawa LM; Halliday C; Stotz SC; Rakai BD; Fu L; Jahagirdar R; Sweeney M; Johansson JO; Wong NCW; Kulikowski E
    Cardiovasc Ther; 2020; 2020():9397109. PubMed ID: 32821285
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Therapeutic targeting of BET bromodomain and other epigenetic acetylrecognition domain-containing factors.
    Gold S; Shilatifard A
    Curr Opin Genet Dev; 2024 Jun; 86():102181. PubMed ID: 38564841
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Bromodomain and Extra-Terminal Domain (BET) Family: Functional Anatomy of BET Paralogous Proteins.
    Taniguchi Y
    Int J Mol Sci; 2016 Nov; 17(11):. PubMed ID: 27827996
    [TBL] [Abstract][Full Text] [Related]  

  • 11. BET Bromodomain as a Target of Epigenetic Therapy.
    Noguchi-Yachide T
    Chem Pharm Bull (Tokyo); 2016; 64(6):540-7. PubMed ID: 27250788
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Apabetalone downregulates factors and pathways associated with vascular calcification.
    Gilham D; Tsujikawa LM; Sarsons CD; Halliday C; Wasiak S; Stotz SC; Jahagirdar R; Sweeney M; Johansson JO; Wong NCW; Kalantar-Zadeh K; Kulikowski E
    Atherosclerosis; 2019 Jan; 280():75-84. PubMed ID: 30476723
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bromodomain and Extraterminal Proteins as Novel Epigenetic Targets for Renal Diseases.
    Morgado-Pascual JL; Rayego-Mateos S; Tejedor L; Suarez-Alvarez B; Ruiz-Ortega M
    Front Pharmacol; 2019; 10():1315. PubMed ID: 31780938
    [TBL] [Abstract][Full Text] [Related]  

  • 14. BET protein inhibitor apabetalone (RVX-208) suppresses pro-inflammatory hyper-activation of monocytes from patients with cardiovascular disease and type 2 diabetes.
    Wasiak S; Dzobo KE; Rakai BD; Kaiser Y; Versloot M; Bahjat M; Stotz SC; Fu L; Sweeney M; Johansson JO; Wong NCW; Stroes ESG; Kroon J; Kulikowski E
    Clin Epigenetics; 2020 Nov; 12(1):166. PubMed ID: 33172487
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epigenetic BET reader inhibitor apabetalone (RVX-208) counters proinflammatory aortic gene expression in a diet induced obesity mouse model and in human endothelial cells.
    Wasiak S; Tsujikawa LM; Daze E; Gilham D; Stotz SC; Rakai BD; Sarsons CD; Fu L; Azhar S; Jahagirdar R; Sweeney M; Johansson JO; Wong NCW; Kulikowski E
    Atherosclerosis; 2023 Jan; 364():10-19. PubMed ID: 36455344
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TP63, SOX2, and KLF5 Establish a Core Regulatory Circuitry That Controls Epigenetic and Transcription Patterns in Esophageal Squamous Cell Carcinoma Cell Lines.
    Jiang YY; Jiang Y; Li CQ; Zhang Y; Dakle P; Kaur H; Deng JW; Lin RY; Han L; Xie JJ; Yan Y; Doan N; Zheng Y; Mayakonda A; Hazawa M; Xu L; Li Y; Aswad L; Jeitany M; Kanojia D; Guan XY; Said JW; Yang W; Fullwood MJ; Lin DC; Koeffler HP
    Gastroenterology; 2020 Oct; 159(4):1311-1327.e19. PubMed ID: 32619460
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Selective inhibition of the BD2 bromodomain of BET proteins in prostate cancer.
    Faivre EJ; McDaniel KF; Albert DH; Mantena SR; Plotnik JP; Wilcox D; Zhang L; Bui MH; Sheppard GS; Wang L; Sehgal V; Lin X; Huang X; Lu X; Uziel T; Hessler P; Lam LT; Bellin RJ; Mehta G; Fidanze S; Pratt JK; Liu D; Hasvold LA; Sun C; Panchal SC; Nicolette JJ; Fossey SL; Park CH; Longenecker K; Bigelow L; Torrent M; Rosenberg SH; Kati WM; Shen Y
    Nature; 2020 Feb; 578(7794):306-310. PubMed ID: 31969702
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The BET Protein Inhibitor Apabetalone Rescues Diabetes-Induced Impairment of Angiogenic Response by Epigenetic Regulation of Thrombospondin-1.
    Mohammed SA; Albiero M; Ambrosini S; Gorica E; Karsai G; Caravaggi CM; Masi S; Camici GG; Wenzl FA; Calderone V; Madeddu P; Sciarretta S; Matter CM; Spinetti G; Lüscher TF; Ruschitzka F; Costantino S; Fadini GP; Paneni F
    Antioxid Redox Signal; 2022 Apr; 36(10-12):667-684. PubMed ID: 34913726
    [No Abstract]   [Full Text] [Related]  

  • 19. BRD3 and BRD4 BET Bromodomain Proteins Differentially Regulate Skeletal Myogenesis.
    Roberts TC; Etxaniz U; Dall'Agnese A; Wu SY; Chiang CM; Brennan PE; Wood MJA; Puri PL
    Sci Rep; 2017 Jul; 7(1):6153. PubMed ID: 28733670
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Epigenetic Reader BRD2 as a Specific Modulator of PAI-1 Expression in Lipopolysaccharide-Stimulated Mouse Primary Astrocytes.
    Choi CS; Hong SH; Sim S; Cho KS; Kim JW; Yang SM; Jeon SJ; You JS; Shin CY
    Neurochem Res; 2015 Nov; 40(11):2211-9. PubMed ID: 26349765
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.